1-3 of 3
progressive massive fibrosis
Close
Sort by
Journal Articles

Outcomes Following Second Allogenic Haematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of EBMT

Mitja Nabergoj, MD, Junfeng Wang, PhD, Marie Robin, MD, Nicolaus Kröger, MD, Emanuele Angelucci, MD, Xavier Poire, Jakob R. Passweg, MDMS, Peter Dreger, Uwe Platzbecker, MD, Stephen Robinson, MBBS, PhD BSc, Alessandro Rambaldi, MD, Henrik Sengeloev, Martin Bornhäuser, MD, Matthias Stelljes, Fabio Ciceri, MD, Jiri Mayer, MD, Marco Ladetto, MD, Liesbeth C. de Wreede, PhD, Linda Koster, Patrick John Hayden, BA, Tomasz Czerw, MD PhD, Juan Carlos Hernandez Boluda, Donal P. McLornan, MB, BCh (Hons), MRCP, PhD FRCPath, Yves Chalandon, Ibrahim Yakoub-Agha, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 698.
https://doi.org/10.1182/blood-2019-125802
Published: 2019
Journal Articles

A Nationwide Epidemiologic Study for Disease Transformation and Secondary Cancers in Korean Patients with Myeloproliferative Neoplasms

Junshik Hong, MD, Ju Hyun Lee, Ja Min Byun, MD, Ji Yun Lee, MD, Hyun Jung Lee, MD, Sang Mee Hwang, MD PhD, Byung-Su Kim, MD PhD, Hyo Jung Kim, MD PhD, Jung Lim Lee, MD, Dong-Yeop Shin, MD PhD, Youngil Koh, MD PhD, Sung-Soo Yoon, MD PhD, Soo-Mee Bang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4314.
https://doi.org/10.1182/blood-2018-99-116298
Published: 2018
Journal Articles

Phase I Study Of LY2784544, a JAK2 Selective Inhibitor, In Patients With Myelofibrosis (MF), Polycythemia Vera (PV), and Essential Thrombocythemia (ET)

Srdan Verstovsek, MD, PhD, Ruben A Mesa, MD, Mohamed E Salama, MD, Jennifer L K Giles, BSc, Celine Pitou, PharmD, Annamaria Hayden Zimmermann, MS, Gregory L Price, MPH, Richard A Walgreen, MD, Josef Prchal, MD
Journal: Blood
Blood (2013) 122 (21): 665.
https://doi.org/10.1182/blood.V122.21.665.665
Published: 2013